4DMedical Limited (ASX:4DX)
Australia · Delayed Price · Currency is AUD 3.150
-0.230 (-6.80%)
At close: Feb 5, 2026
4DMedical Market Cap
4DMedical has a market cap or net worth of 1.79 billion as of February 5, 2026. Its market cap has increased by 667.11% in one year.
Market Cap
1.79B
Enterprise Value
1.79B
Revenue
5.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.15
Market Cap Chart
Since August 7, 2020, 4DMedical's market cap has increased from 420.97M to 1.79B, an increase of 326.36%. That is a compound annual growth rate of 30.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 1.93B | -8.18% |
| Dec 31, 2025 | 2.10B | 961.67% |
| Dec 31, 2024 | 197.57M | -29.31% |
| Dec 29, 2023 | 279.48M | 125.82% |
| Dec 30, 2022 | 123.76M | -68.87% |
| Dec 31, 2021 | 397.56M | -38.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 7, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cochlear | 17.45B |
| Anteris Technologies Global | 837.17M |
| PolyNovo | 683.93M |
| Aroa Biosurgery | 239.80M |
| Lumos Diagnostics Holdings | 213.96M |
| EMVision Medical Devices | 168.22M |
| SomnoMed | 141.99M |
| Cleo Diagnostics | 91.70M |